Elicio Therapeutics
ELTX
41 hedge funds and large institutions have $91.9M invested in Elicio Therapeutics in 2021 Q1 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.65% more ownership
Funds ownership: 0% → 1.65% (+1.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$18.7M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$16.9M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.9M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$11.9M |
| 5 |
BlackRock
New York
|
+$6.05M |
Top Sellers
ELTX Hedge Fund Activity: Q1 2021 in Review
41 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Elicio Therapeutics (ELTX) for Q1 2021, worth a combined $91.9M.
Buyers outnumbered sellers: 41 funds opened new ELTX positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Park West Asset Management, opening a new position worth an estimated $18.7M.
- 41 institutional investors held Elicio Therapeutics (ELTX) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $91.9M of Elicio Therapeutics stock for Q1 2021.
- 41 funds opened new Elicio Therapeutics positions in Q1 2021 and 0 closed out, a net change of +41 holders.
- The largest Elicio Therapeutics buyer in Q1 2021 was Park West Asset Management, an estimated $18.7M added.
Based on aggregated 13F filings for Q1 2021.